Prelude Capital Management, LLC Twist Bioscience Corp Transaction History

Prelude Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$38.58 - $83.27 $106,982 - $230,907	-2,773 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$75.47 - $135.88 $24,678 - $44,432	-327 Reduced 10.55%	2,773 $215,000
Q3 2021 Nov 15, 2021	BUY	$95.64 - $131.48 $296,484 - $407,587	3,100 New	3,100 $332,000
Q2 2021 Aug 16, 2021	SELL	$88.13 - $142.06 $469,204 - $756,327	-5,324 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$105.48 - $207.97 $179,737 - $354,380	-1,704 Reduced 24.25%	5,324 $659,000
Q4 2020 Feb 16, 2021	SELL	$76.64 - $167.89 $251,839 - $551,686	-3,286 Reduced 31.86%	7,028 $993,000
Q3 2020 Nov 16, 2020	SELL	$45.46 - $78.79 $571,250 - $990,075	-12,566 Reduced 54.92%	10,314 $784,000
Q2 2020 Aug 14, 2020	BUY	$26.4 - $45.3 $604,032 - $1.04 Million	22,880 New	22,880 $1.04 Million

256

66.8M

127K

45.4K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.38B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.